Australian Technical Advisory Group on Immunisation (ATAGI) advice for immunisation providers regarding the administration of seasonal influenza vaccines in 2017

Australia
NITAGs
6 March 2017

During its 62nd meeting in February 2017, ATAGI endorsed its recommendation for annual influenza vaccination for any person ≥6 months of age who wishes to reduce the likelihood of becoming ill with influenza.

drapeau-australie.jpg

Key points:

  • Annual vaccination is the most important measure to prevent influenza and its complications.
  • Annual influenza vaccination is recommended for any person ≥6 months of age who wishes to reduce the likelihood of becoming ill with influenza.
  • Recent evidence suggests protection against influenza may start to decrease from 3 to 4 months following vaccination and early vaccination needs to be balanced with this. While influenza continues to circulate, it is never too late to vaccinate.
  • Only quadrivalent influenza vaccines (QIV) formulations are available in Australia in 2017. Age restrictions apply according to vaccine brand (refer to Table 1).
  • QIVs are funded on the National Immunisation Program (NIP) in 2017 for the following groups:
    • Aboriginal and/or Torres Strait Islander children aged 6 months to <5 years
    • Aboriginal and/or Torres Strait Islander persons aged ≥15 years
    • All persons aged ≥65 years
    • All persons aged ≥6 months who have certain medical conditions which increase the isk of influenza disease complications; for example, severe asthma, lung or heart disease, low immunity or diabetes (refer to Table 3).
    • Pregnant women (during any stage of pregnancy).
  • Influenza vaccination is also strongly recommended, but not funded, for other groups who are at increased risk of influenza and its complications (refer to Table 3 footnote).
  • Persons with egg allergy, including anaphylaxis, can be safely vaccinated with influenza vaccines. Persons with a history of anaphylaxis to egg can be vaccinated with a full vaccine dose in medical facilities with staff experienced in recognising and treating anaphylaxis.
  • Providers are reminded to report all vaccines given to the Australian Immunisation Register.
Documents to download

Related News & Events

  • Côte d’Ivoire
    NITAGs

    ESTABLISHMENT AND STRENGTHENING OF NITAG IN IVORY COAST: SUCCESS AND CHALLENGES

    26.04.2017

    The NITAG session at the April SAGE meeting 2017 includes presentations of three committees: JCVI (UK NITAG), Sri Lanka and Senegal. The NITAG of Cote d'Ivoire is taking this opportunity to present its success and challenges.

    Read more
  • NITAGs

    Get ready for the next GNN meeting and read the 2016 report

    21.04.2017

    The Global NITAG Network will meet in June 28th - 29th, 2017 in Berlin. The Organizing Committee composed of representatives of the Robert Koch Institute (as the hosting institutions), AMP-HPID, US CDC, WHO and representatives from the NITAG network are currently developing the meeting agenda. Last year report can be downloaded to get prepared for this year meeting and get familiarized with the NITAG members. 

    Read more
  • Costa Rica
    NITAGs

    Voice from the field: Roberto Arroba

    10.04.2017

    Roberto Arroba is the National coordinator of immunization in Costa Rica, in charge of the secretariat of the NITAG and also a core group member of the Global NITAG Network (GNN).

    Read more